COMMUNIQUÉS West-GlobeNewswire

K2M Names Lane Major Chief Operating Officer
29/03/2018
LEESBURG, Va., March 29, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Mustang Bio Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights
29/03/2018
NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
Chimerix Announces Martha J. Demski as Board Chair; Appoints New Members to Board of Directors
29/03/2018
DURHAM, N.C., March 29, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced the appointment of Martha J. Demski as [...]
Reata Announces That Kyowa Hakko Kirin Received SAKIGAKE Priority Review Designation for Bardoxolone Methyl in Japan
29/03/2018
IRVING, Texas, March 29, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a clinical-stage biopharmaceutical company, today announced that its licensee, Kyowa Hakko Kirin Co. Ltd [...]
CohBar, Inc. Announces Closing of First Tranche of Private Placement
29/03/2018
MENLO PARK, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR ) (TSXV:COB.U) (“CohBar” or the “Company”) is pleased to announce the closing of its first tranche of its previously announced private [...]
resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results
29/03/2018
BOSTON, March 29, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of [...]
Ovid Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Progress
29/03/2018
-- Enrollment Completed in Phase 2 STARS Clinical Trial in Adults and Adolescents with Angelman Syndrome; Topline Data Expected Third Quarter 2018 -- -- Enrollment Ongoing in Phase 1b/2a Clinical Trial of TAK-935/OV935 [...]
KemPharm Reports Fourth Quarter and Year End 2017 Results
29/03/2018
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development & Regulatory Highlights: FDA Approval Announced of APADAZ™ (benzhydrocodone and acetaminophen) for the [...]
Recro Pharma Announces Commercial Team Additions
29/03/2018
MALVERN, Pa., March 29, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
Marrone Bio Innovations, Inc. Reports Record Full Year 2017 Financial Results
29/03/2018
DAVIS, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (“MBI” or the “Company”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, [...]
Spine Injury Solutions Announces Results for the Fiscal Full Year Ended December 31, 2017
29/03/2018
HOUSTON, March 29, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), today announced financial results for its fiscal 2017 year ended December 31, 2017. Dr. William Donovan, Chairman and Chief [...]
IntelGenx Reports Fourth Quarter and Full-Year 2017 Financial Results
29/03/2018
SAINT LAURENT, Quebec, March 29, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX ) (OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter and twelve-month [...]
CV Sciences, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
29/03/2018
- Record Year on All Key Financial Performance Metrics - Management to Host Webcast on March 29, 2018 to Discuss Q4 2017 and Full Year 2017 Operating Results LAS VEGAS, March 29, 2018 (GLOBE NEWSWIRE) -- CV Sciences, [...]
CORRECTION: FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
29/03/2018
FIT Biotech Oy Company release March 29, 2018 at 8:30 pm EET Correction to company release March 29, 2018 - FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants - authorization [...]
TOMI™ Environmental Solutions, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
29/03/2018
BEVERLY HILLS, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, [...]
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
29/03/2018
Press release - Regulated information - 29 March 2018, 5.45 p.m. CET HERSTAL, BELGIUM and IRVINE, CA - March 29, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), a world leader in molecular [...]
MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire
29/03/2018
C ommuniqué de presse - Information réglementée - 29 mars 2018, 1 7h45 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 29 mars 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), un leader mondial [...]
Theratechnologies to Announce Financial Results for First Quarter 2018
29/03/2018
MONTREAL, March 29, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) ( Theratechnologies ) announced today that it will issue its financial results for the first quarter ended February 28, 2018, on Thursday, [...]
Theratechnologies annoncera ses résultats du premier trimestre de 2018
29/03/2018
MONTRÉAL, 29 mars 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX: TH ) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers jeudi le 5 avril 2018 pour l’exercice financier [...]

Pages